位置 | 年龄 | 性别 | 标本部位 | 病理分类 | 病理分级 | TNM_T | TNM_N | TNM_M |
A1 | 28 | F | 乳腺,Breast | 导管原位癌;Ductal carcinoma in situ | Tis | N0 | M0 |
A2 | 63 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T4 | N3 | M0 |
A3 | 43 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 |
A4 | 74 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 |
A5 | 60 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T4 | N3 | M0 |
A6 | 49 | F | 乳腺,Breast | 乳头状腺癌;Papillary carcinoma | II | Tis | N0 | M0 |
B1 | 41 | F | 乳腺,Breast | 导管原位癌;Ductal carcinoma in situ | I | Tis | N0 | M0 |
B2 | 43 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 |
B3 | 44 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
B4 | 50 | F | 乳腺,Breast | 导管原位癌;Ductal carcinoma in situ | Tis | N0 | M0 |
B5 | 62 | F | 乳腺,Breast | 浸润性小叶癌;Invasive lobular carcinoma | I | T3 | N1 | M0 |
B6 | 54 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 |
C1 | 43 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | I~II | T2 | N1 | M0 |
C2 | 48 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
C3 | 40 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 |
C4 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 |
C5 | 35 | F | 乳腺,Breast | 浸润性小叶癌;Invasive lobular carcinoma | I | T2 | N0 | M0 |
C6 | 92 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T4 | N1 | M0 |
D1 | 41 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
D2 | 30 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 |
D3 | 28 | F | 乳腺,Breast | 浸润性小叶癌;Invasive lobular carcinoma | I~II | T2 | N1 | M0 |
D4 | 42 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 |
D5 | 50 | F | 乳腺,Breast | 浸润性小叶癌;Invasive lobular carcinoma | I | T4 | N1 | M0 |
D6 | 68 | F | 乳腺,Breast | 浸润性小叶癌;Invasive lobular carcinoma | II~III | T4 | N1 | M0 |
E1 | 64 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 |
E2 | 56 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 |
E3 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T3 | N0 | M0 |
E4 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T3 | N3 | M0 |
E5 | 65 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 |
E6 | 50 | F | 乳腺,Breast | 导管原位癌;Ductal carcinoma in situ | I | Tis | N0 | M0 |
F1 | 47 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T3 | N2 | M0 |
F2 | 53 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
F3 | 51 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T4 | N0 | M0 |
F4 | 44 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 |
F5 | 45 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
F6 | 51 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | I~II | T2 | N1 | M0 |
G1 | 33 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 |
G2 | 42 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 |
G3 | 48 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
G4 | 61 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T3 | N1 | M0 |
G5 | 37 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 |
G6 | 44 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | I | T2 | N1 | M0 |
H1 | 55 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 |
H2 | 31 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
H3 | 46 | F | 乳腺,Breast | 浸润性小叶癌;Invasive lobular carcinoma | I | T3 | N1 | M0 |
H4 | 36 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 |
H5 | 57 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N1 | M0 |
H6 | 52 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T3 | N1 | M0 |
I1 | 37 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | T2 | N0 | M0 |